Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–50 of 567 pages matching "Parkinson's disease"

🏥 Parkinson's DiseaseKG

disease · 8,807 words · 135 hyp40 ana152 exp

⚙️ Mitochondrial Dysfunction in Parkinson's DiseaseKG

mechanism · 4,972 words · 43 hyp51 ana68 exp

⚙️ Synaptic Vesicle Trafficking in Parkinson's DiseaseKG

mechanism · 4,417 words · 39 hyp53 ana61 exp

⚙️ GBA Pathway in Parkinson's DiseaseKG

mechanism · 4,381 words · 25 hyp47 ana75 exp

⚙️ LRRK2 Kinase Activation and Endolysosomal Dysfunction in Parkinson's DiseaseKG

mechanism · 4,337 words · 26 hyp48 ana82 exp

⚙️ Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's DiseaseKG

mechanism · 4,302 words · 16 hyp45 ana65 exp

⚙️ LRRK2 Pathway in Parkinson's DiseaseKG

mechanism · 4,238 words · 22 hyp46 ana82 exp

⚙️ Insulin Signaling in Parkinson's DiseaseKG

mechanism · 4,072 words · 103 hyp67 ana76 exp

⚙️ DNA Damage Response in Parkinson's DiseaseKG

mechanism · 3,987 words · 75 hyp46 ana116 exp

⚙️ Synuclein Pathway in Parkinson's DiseaseKG

mechanism · 3,901 words · 22 hyp46 ana63 exp

⚙️ ATP13A2 Lysosomal Dysfunction Pathway in Parkinson's DiseaseKG

mechanism · 3,852 words · 29 hyp49 ana63 exp

⚙️ Calcium Signaling Dysregulation in Parkinson's DiseaseKG

mechanism · 3,753 words · 148 hyp70 ana60 exp

💊 Parkinson's Disease TreatmentKG

therapeutic · 3,641 words · 6 hyp20 ana63 exp

Endocannabinoid System Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,520 words · 6 hyp23 ana70 exp

⚙️ TGF-β Signaling in Parkinson's DiseaseKG

mechanism · 3,514 words · 54 hyp45 ana76 exp

🔬 Tuberoinfundibular Dopamine Neurons in Parkinson's DiseaseKG

cell · 3,441 words · 7 hyp22 ana59 exp

⚙️ Neuroinflammation in Parkinson's DiseaseKG

mechanism · 3,418 words · 25 hyp49 ana80 exp

⚙️ cGAS-STING Signaling in Parkinson's DiseaseKG

mechanism · 3,408 words · 46 hyp42 ana69 exp

⚙️ UCHL1 (PARK5) Pathway in Parkinson's DiseaseKG

mechanism · 3,394 words · 18 hyp47 ana63 exp

⚙️ Ion Channel Dysfunction in Parkinson's DiseaseKG

mechanism · 3,382 words · 17 hyp48 ana60 exp

🏥 Caregiver Support and Palliative Care in Atypical [Parkinson's disease](/diseases/parkinsons-disease)ismKG

disease · 3,381 words · 3 hyp19 ana123 exp

🧪 Vagal Nerve Stimulation for Parkinson's Disease (NCT07226284)KG

clinical · 3,330 words · 10 hyp15 ana62 exp

⚙️ Mitochondria-Lysosome Contact Site Dysfunction in Parkinson's DiseaseKG

mechanism · 3,314 words · 179 hyp73 ana74 exp

⚙️ DJ-1 Oxidative Stress Response Pathway in Parkinson's DiseaseKG

mechanism · 3,285 words · 32 hyp46 ana63 exp

⚙️ Non-Dopaminergic Neurotransmitter Degeneration as Upstream Driver in Parkinson's DiseaseKG

mechanism · 3,250 words · 11 hyp43 ana64 exp

🏥 DLB, Parkinson's Disease, and Alzheimer's Disease: Cross-Disease Comparison MatrixKG

disease · 3,237 words · 58 hyp35 ana294 exp

🏢 Astrocyte-Targeted Parkinson's Disease Therapy CompaniesKG

company · 3,233 words · 126 hyp69 ana72 exp

⚙️ Nurr1 (NR4A2) Pathway in Parkinson's DiseaseKG

mechanism · 3,218 words · 20 hyp48 ana60 exp

⚙️ VPS35 Retromer Dysfunction Parkinson's Disease Causal ChainKG

mechanism · 3,215 words · 5 hyp43 ana63 exp

⚙️ TREM2 in Parkinson's Disease — Cross-Disease Therapeutic OpportunityKG

mechanism · 3,181 words · 42 hyp60 ana99 exp

⚙️ Autophagy-Lysosomal Pathway in Parkinson's DiseaseKG

mechanism · 3,178 words · 138 hyp71 ana69 exp

⚙️ Lichen-derived Neuroprotective Compounds for Parkinson's DiseaseKG

mechanism · 3,160 words · 14 hyp42 ana70 exp

Wnt-Beta-Catenin Signaling Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,146 words · 42 hyp33 ana67 exp

⚙️ Shared Proteinostasis Failure in Alzheimer's and Parkinson's DiseaseKG

mechanism · 3,143 words · 29 hyp50 ana61 exp

🔧 Digital Therapeutics for Parkinson's DiseaseKG

technology · 3,124 words · 9 hyp18 ana71 exp

Stress Granule Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,115 words · 176 hyp69 ana75 exp

📊 Alpha-Synuclein Seed Kinetic Staging in Parkinson's DiseaseKG

biomarker · 3,114 words · 9 hyp18 ana74 exp

⚙️ GBA Gene Mutations and Parkinson's Disease RiskKG

mechanism · 3,113 words · 40 hyp45 ana78 exp

💊 FMT for Parkinson's DiseaseKG

therapeutic · 3,112 words · 15 ana61 exp

Regulated Necrosis Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,098 words · 3 hyp20 ana65 exp

Vesicular Monoamine Transporter 2 (VMAT2) Pathway in Parkinson's DiseaseKG

mechanisms · 3,096 words · 6 hyp45 ana60 exp

⚙️ Sirtuin Signaling in Parkinson's DiseaseKG

mechanism · 3,093 words · 52 hyp44 ana63 exp

⚙️ EGFR Signaling in Parkinson's DiseaseKG

mechanism · 3,091 words · 44 hyp40 ana63 exp

⚙️ Ubiquitin-Proteasome System Dysfunction in Parkinson's DiseaseKG

mechanism · 3,071 words · 9 hyp44 ana65 exp

Mitochondrial Dynamics Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,069 words · 20 hyp33 ana64 exp

📊 Blood Microbial Signatures in Parkinson's DiseaseKG

biomarker · 3,060 words · 184 hyp65 ana70 exp

💊 CSF1R Inhibitors for Parkinson's DiseaseKG

therapeutic · 3,030 words · 23 hyp27 ana72 exp

cGAS-STING Pathway Dysregulation Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,017 words · 40 hyp45 ana74 exp

💊 Vagus Nerve Stimulation for Parkinson's DiseaseKG

therapeutic · 2,997 words · 6 hyp19 ana59 exp

⚙️ Parkinson's Disease MechanismsKG

mechanism · 2,994 words · 28 hyp48 ana69 exp